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background: The aim of this study was to investigate the effect of chromosomal polymorphic variations on the outcome of IVF and
embryo transfer (IVF–embryo transfer) treatment for infertile couples.
methods: During the period from October 2006 to December 2009, 1978 infertile couples who had received their ﬁrst IVF–embryo
transfer treatment cycle in our hospital were selected for this retrospective study, and the frequency of chromosomal polymorphic variations
was calculated. From these, 1671 couples were selected and divided into three groups: 1402 couples with normal chromosomes (Group 1/
control group), 82 couples with chromosomal polymorphic variations in only females (Group 2) and 187 couples with chromosomal poly-
morphic variations in only males (Group 3). The clinical pregnancy rates (CPR), early miscarriage rates and ongoing pregnancy rates after
IVF–embryo transfer treatment were compared.
results: There were no statistically signiﬁcant differences among the three groups in implantation rates (29.37% in the control group,
29.70% in Group 2 and 31.41% in Group 3, P . 0.05) and CPR (45.86, 46.34 and 51.87%, respectively, P . 0.05). Although there was
a trend toward higher ﬁrst trimester pregnancy loss rates in Group 3 (male chromosomal polymorphic variations), but not in Group 2, com-
pared with normal karyotype couples (10.31 versus 6.84%), the difference did not reach signiﬁcance (P . 0.05).
conclusions: Chromosomal polymorphic variations appear to have no adverse effects on the outcome of IVF–embryo transfer
treatment.
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Introduction
Polymorphism variations mainly refer to the variants in the chromoso-
mal heterochromatin region. Polymorphic variants on non-acrocentric
chromosomes usually occur in the paracentric heterochromatin on the
long arms of chromosomes 1, 9 and 16, the short-arm regions of D
and G group chromosomes, and the distal heterochromatin of the Y
chromosome. Increased lengths of the heterochromatic regions on
the long arms of these chromosomes are designated as 1qh+,
9qh+, 16qh+ and Yqh+. Sometimes, the heterochromatin is
reduced in these chromosomes, such as 1qh2, 9qh2 and 16qh2.
Increased lengths of the short-arm satellites and stalks of the acro-
centric D and G group chromosomes (13, 14, 15, 21 and 22) are
designated, for example, as 14ps+ and 13pstk+, while increased
lengths of the short arms themselves are designated as p+ (e.g.
15p+)( Madon et al., 2005). For the heterochromatin that is
formed by tandemly organized, highly repeated sequences of satellite
DNA that do not encode proteins, the chromosomal polymorphism
variations are considered normal karyotypes (Bhasin, 2005).
However, more and more studies indicate that chromosome poly-
morphisms may cause certain clinical effects, such as infertility and
spontaneous miscarriage (Madon et al., 2005; Yuce et al., 2007;
Sahin et al., 2008). Chromosome polymorphic variation is found to
be higher in infertile patients, especially those receiving IVF and
embryo transfer (IVF–embryo transfer) treatment, than in people
with normal fertility (Madon et al., 2005; Sahin et al., 2008; Minocher-
homji et al., 2009). For example, in the study by Minocherhomji et al.
(2009), the frequency of chromosomal polymorphism variation in 760
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found a higher frequency of chromosomal polymorphism variations
in infertile couples with ICSI and IUI treatment (28.31 versus
15.16%, infertile women versus fertile controls, P ¼ 0.0007; 58.68
versus 32.55%, infertile men versus fertile controls, P ¼ 0.0002). In
a controlled study by Madon et al. (2005), 842 patients who were
ready for IVF–embryo transfer treatment for primary infertility or a
history of multiple miscarriages were compared with the general
population of the retrospective study by Bhasin (2005). They found
that polymorphic variations such as 9qh+, Yqh+ and D/G group
were more common in patients who were ready for IVF–embryo
transfer treatment (7.6 versus 2.44%; 7.86 versus 2.85% and 8.91
versus 3.96%, respectively). According to these reports, chromosomal
polymorphic variations cannot be ignored by clinicians. Therefore,
whether polymorphic variants of chromosomes affect the outcome
of assisted reproductive technique (ART) treatment has aroused
general concern. Clinicians have speculated that infertile individuals
with chromosomal polymorphic variations should use donor
gametes or be treated with preimplantation genetic screening or
undergo preimplantation genetic diagnoses. However, the literature
regarding chromosome polymorphism in infertile couples has mainly
focused on screening. Very few studies concerning the impact of chro-
mosomalpolymorphicvariationsonARTtreatmenthavebeenreported
(Silberet al., 1998; van Golde et al., 2001; Oates et al., 2002; Choi et al.,
2004;Kihaileetal.,2005;Yakinetal.,2005).Thesestudiesconcentrated
on infertile men with severe oligozoospermia, azoospermia or Y
chromosome variation, and the outcome of ICSI treatment. No
report has studied whether chromosomal variation, other than Y
chromosome variation, affects the outcome of IVF–embryo transfer
treatment, including traditional IVF. More data are needed to resolve
this question. Therefore, this retrospective study comprehensively ana-
lyzed the correlation between chromosome polymorphisms and the
outcome of IVF–embryo transfer treatment for infertile couples who
were treated in our department during the last 3 years.
Materials and Methods
Subjects and karyotype analysis
AretrospectiveanalysiswasconductedofalltheIVFandICSItreatmentsper-
formed from October 2006 up to and including 12 December 2009 at the
Department of Reproductive Medicine, Renji Hospital of Shanghai Jiaotong
University. Only data from the ﬁrst cycles were used. Excluding couples
with abnormal chromosome karyotypes, the frequency of chromosomal
polymorphic variations was detected in a total of 1978 infertile couples.
Chromosome karyotype analysis was carried out on peripheral blood
lymphocytes for all infertile couples before ART. Peripheral blood lympho-
cytes were stimulated and cultured for 72 h, and then stained with the
G-banding technique. At least 20 meta-phases were analyzed for each
case, and ﬁve meta-phases were karyotyped using light microscopy. The
banding resolution was 400–550 bands per haploid set (BPHS).
C-banding and R-banding staining methods were adopted (when necess-
ary) to assist karyotype analysis.
Heteromorphisms were reported according to International System for
Chromosome Nomenclature 2009 after selective banding studies, such as
C and nucleolar organizing region (NOR) banding, were conducted.
Visualized polymorphic variations in the length of the centromeric
heterochromatin on the long arms of chromosomes 1, 9 and 16
(1qh+/2, 9qh+/2 and 16qh+/2), and the distal heterochromatic
region of chromosome Y (Yqh+/2) were documented. Distinct poly-
morphic variants of the size of satellites (ps+) and lengths of stalks
(pstk+) of the acrocentric (acro) chromosomes were also recorded.
To be classiﬁed as variants, heteromorphisms needed to be at least
twice the size of the corresponding region on the other homolog.
This served as an internal control to rule out cultural artifacts in a majority
of meta-phases studied. Polymorphisms of the Y chromosome were
evaluated such that Yqh+ occurred when it was larger than chromosome
18, and Yqh2 occurred when the Y chromosome was smaller than the
G-group chromosome (Hsu et al., 1987). The pericentric inversion of
chromosomes 9 and Y were also considered a heteromorphism.
When heteromorphisms were detected, all karyotypes were examined
by three independent laboratory technicians to avoid uncertainty and
variable results.
Overall, 289 couples were eliminated from the study of the outcome
of IVF–embryo transfer treatment for reasons including: female partner
age .38 years, female basal FSH .10 IU/l, female partner with ovulation
dysfunction (such as polycystic ovarian syndrome), female partner with
anatomic defects of the reproductive system, female partner undergone
reproductive system surgery and poor obstetric history (including spon-
taneous miscarriage, stillbirth and children with malformations or genetic
abnormalities).
Thus 1689 infertile couples were grouped according to the karyotype
analysis results: Group 1 (control group) included 1402 couples with
normal chromosomes; Group 2 included 82 couples with polymorphic
variants of chromosomes in only females; Group 3 included 187 couples
with polymorphic variants of chromosomes in only males. There were
18 other infertile couples with polymorphic variants of chromosomes in
both males and females. They were excluded from the study because of
their small number.
The stimulation protocol included the long and short down-regulation
protocol. The long-term pituitary down-regulation started from the late
luteal phase. After that, 150–225 IU of FSH were injected daily. The
short-term pituitary down-regulation began on the cycle day 2 or day
3. When there were more than three follicles with diameter ≥18 mm
in bilateral ovaries, hCG was injected intramuscularly at a dose of
5000–10 000 IU, and the oocytes were retrieved 34–36 h later. Tra-
ditional IVF or ICSI was performed 4–6 h after the oocyte retrieval pro-
cedure, and the fertilization of oocytes was checked the next day. The
embryo-transfer procedure was performed on Day 2 or Day 3 according
to embryo development and patient condition. Oocyte retrieval pro-
cedures without embryo transfer were excluded from the study.
Blood or urine b-hCG levels were tested 14 days after the embryo-
transfer procedure to conﬁrm biochemical pregnancy. The gestational
sac seen on ultrasonography was used as evidence of clinical pregnancy
4 weeks after the embryo-transfer procedure. Pregnancy termination
before 10 weeks after the oocyte retrieval procedure (corresponding to
a gestational age of 12 weeks) was considered early miscarriage. Pregnancy
over 10 weeks after the oocyte retrieval procedure was considered
ongoing pregnancy.
The clinical pregnancy rates (CPR), embryo implantation rates (IRs),
early miscarriage rates and ongoing pregnancy rates (OPRs) of fresh
embryo transfer were calculated and compared between the three groups.
Statistical analysis
SPSS 16.0 software was used for statistical analysis. P ≤ 0.05 was con-
sidered signiﬁcant. One-way ANOVA was used to test numerical data.
The exact x
2 or Fisher’s exact probability test was used to test for signiﬁ-
cant differences of categorical data.
A binary logistic regression model was used to compute the odds ratios
(ORs) of the chromosomal polymorphic variations as variables predictive
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embryo transfer. Other independent variables included female age, IVF
or ICSI, female basal FSH, protocol of ovarian stimulation, sperm par-
ameters, dosage of gonadotrophin (Gn) used for controlled ovarian hyper-
stimulation, estradiol level on the day of HCG injected, thickness of
endometrium on HCG day, number of oocytes obtained and number of
high-quality embryos transferred. All of the above variables were categori-
cal variables or were transformed into categorical variables. Chromosomal
polymorphic variation was a multicategorical variable, with the different
values having no real numerical relationship with each other; this was a
code to a dummy variable. The control group was the category to
which the other two categories were compared.
Results
The incidence of chromosomal polymorphic variations in infertile
couples is shown in Table I. The most common variant observed
was Yqh+ in infertile men (145, 7.33%). Other chromosomal variants
with a high incidence included 1qh+ (34 in women, 1.72%) and
16qh+ (19 in women, 0.96%). Inv(9) was the least common poly-
morphic variation in infertile couples (18, 0.91% in men; 13, 0.66%
in women).
The basal data of the three groups were compared by two
methods. Statistical analyses of not only numerical data, but also cat-
egorical data, showed no differences among the three groups for the
methods of insemination, female ages, infertility years, etiology of
infertility, female basal FSH, endometrial thickness, number of
oocytes retrieved and the numbers of high-quality embryos trans-
ferred (P . 0.05; Table II).
Table III shows no differences between the polymorphic groups and
the control group in the IR, CPR and OPR (P . 0.05). Compared with
the control group, Group 2 (women with polymorphic chromosome
variants) had a similar early miscarriage rate (7.89 versus 6.84%,
.............................................................................................................................................................................................
Table I Frequency of chromosomal polymorphism variation.
Karyotypes No. of males with
heteromorphism
(n 5 1978)
Frequency
(%)
No. of females with
heteromorphism (n 5 1978)
Frequency
(%)
Total 258 13.04 114 5.76
1, 9, 16qh+ 39 1.97 65 3.29
1qh+ 22 34
9qh+ 51 9
16qh+ 10 9
1qh+16qh+ 11
9qh+16qh+ 02
1qh+9qh+ 10
Chromosome variation
in D/G genomes
43 2.17 35 1.77
13ps+ 40
14p+ 65
15p+ 91 1
13cenh+ 20
14cenh+ 01
15cenh+ 36
21p+ 58
22ps+ 12 4
22cenh+ 10
15p12,21p12 1 0
Inv(9) 18 0.91 13 0.66
Y chromosome
variation
155 7.84
Yqh+ 145
Yqh2 7
inv(Y) 3
Multiple variation 3 1
1qh+,15ps+ 10
9qh2 01
1qh+,inv(9)(p12q13) 1 0
Yqh+,16qh+ 10
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Table II Basal characteristics of infertile couples.
Group 1 (n 5 1402) Group 2 (n 5 82) Group 3 (n 5 187) P
a P
b,c
Method of insemination
IVF cycles 657 37 74 0.17
b
ICSI cycles 745 45 113
Female age (years) Mean+SD 29.56+3.54 29.78+3.13 29.47+3.57 0.80
,25 86 4 15 0.79
c
25–29 636 37 85
30–34 538 36 68
≥35 142 5 19
Etiology of infertility
Tubal factor 410 24 51 0.52
c
Male factor 592 34 93
Multiple factor 368 21 40
Idiopathic 32 3 3
Basal FSH (IU/l) Mean+SD 6.70+1.50 6.85+1.38 6.61+1.48 0.48
,8 1121 65 151 0.95
b
8–10 281 17 26
Protocol of ovarian stimulation 0.15
b
Long 1026 66 142
Short 376 14 45
Sperm parameters
Normal 442 27 54 0.85
b
Oligozoospermia 285 19 42
Severe oligozoospermia and
azoospermia
675 36 91
Dosage of Gn (IU) Mean+SD 1619.33+529.99 1543.15+412.82 1556.35+426.31 0.15
≤1125 201 9 24 0.36
c
1126–2999 1166 72 162
≥3000 35 1 1
E2 level on HCG day (pg/ml) Mean+SD 3504.53+1711.38 3370.82+1653.96 3418.36+1606.33 0.66
≤1000 39 3 5 0.53
c
1001–3499 971 58 142
3500 392 21 40
Thickness of endometrium on
HCG day (mm)
Mean+SD 9.86+1.85 9.94+1.79 10.1+2.13 0.23
≤7 118 6 20 0.92
b
.7 1284 76 157
Numbers of oocytes obtained Mean+SD 12.72+6.54 12.07+5.46 12.71+6.42 0.68
≤5 171 12 26 0.92
b
6–15 799 46 107
.15 432 24 54
Numbers of high-quality
embryos transferred
Mean+SD 1.73+0.67 1.67+0.72 1.68+0.68 0.55
0 111 8 16 0.90
c
1 227 15 34
2 1000 55 131
36 4 4 6
aOne-way ANOVA.
bx
2.
cFisher’s exact test.
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iants) had a higher miscarriage rate (10.31 versus 6.84%), though
the difference was not signiﬁcant (P . 0.05). Further subgroup analysis
according to the male sperm parameters also did not demonstrate sig-
niﬁcant difference neither in couples with normal sperm parameters
(Table IV) or in those with oligozoospermia and azoospermia
(Table V).
Results of the binary logistic regression model are shown in
Table VI. The model resulting from the analysis yielded ORs for
CPR, the early miscarriage rate and OPR. Some potential confounders
showed an effect on the CPR and OPR; for example, the long-term
down-regulation protocol showed a much better treatment
outcome than the short-term protocol (OR for CPR 0.428, P ,
0.001; OR for OPR 0.423, P , 0.001); the dosage of Gns displayed
a negative correlation with the CPR (OR for CPR 0.739, P ¼
.0030), and similar trend with OPR (OR for OPR 0.758, P ¼ 0.051)
and the more high-quality embryos that were transferred, the higher
was the pregnancy rate obtained (OR for CPR 1.574, P , 0.001;
OR for OPR 1.490, P , 0.001). Furthermore, other factors such as
sperm parameters and female age had no effect on the outcome of
IVF/ICSI treatment. After adjusting for these factors, Group 2
(female polymorphism variation couples) displayed similar CPR,
OPR and early miscarriage rates to Group 1 (ORs 0.993, 1.034 and
1.210, respectively, P . 0.05). Group 3 (male polymorphism variation
couples) seemed to have a higher CPR (1.310-fold higher than
Group 1) and higher early miscarriage rate (1.620-fold higher than
Group 1); however, neither difference was signiﬁcant (P ¼ 0.095
and P ¼ 0.140, respectively).
Discussion
Chromosomal polymorphism variation, a synonym of chromosomal
heteromorphism, was considered normal for a long period of time.
In recent years, more and more studies have shown an increased inci-
dence of chromosomal polymorphism variation in infertile couples.
There seems to be some relationship between chromosomal poly-
morphism variation and decreased fertility; however, the impact of
chromosomal heteromorphism on infertility treatments such as
IVF–embryo transfer remains unknown. In 2005, Yakin investigated
210 infertile males who were involved in ICSI treatment; they found
that the CPRs and IRs were signiﬁcantly lower for men with hetero-
chromatin polymorphism than those of normal karyotype (CPR 21.7
versus 40.6%; IR 12.9 versus 19.9%). However, since this study inves-
tigated only infertile couples in which the male partner presented with
severe oligoasthenoteratozoospermia (OAT) and non-obstructive
azoospermia (NOA), the results do not fully reﬂect the impact of
chromosomal polymorphisms on the outcome of IVF and embryo-
transfer techniques.
In the present study, more infertile couples, including male partners
presenting with normal sperm parameters, mild to moderate OAT
and obstructive azoospermia, as well as infertile males presenting
with NOA or OAT were enrolled. Traditional IVF transfer cycles
were also included. The effect of chromosomal heteromorphism
expression on the outcome of IVF/ICSI treatment in infertile
women was also evaluated. The outcomes of IVF/ICSI treatment
were also compared in subgroups of normal and abnormal sperm par-
ameters. Furthermore to eliminate the effect of sperm parameters and
insemination methods, the ratios of these variables among the three
groups were evaluated and found to be no different, even when
using a logistic regression model to analyze the effects of these vari-
ables with respect to IVF/ICSI treatment.
The IR, CPR and OPR were ﬁrst compared among the three groups
by the x
2 method, and no difference was found, even in subgroups
according to sperm parameters. The male carrier group with oligo-
zoospermia and azoospermia displayed a higher IR, CPR and OPR,
........................................................................................
Table III Comparison of the outcomes of fresh IVF–
embryo transfer cycles among the three groups.
Group 1 Group2 Group 3 P
Implantation rate 29.37%
(843/2870)
29.70%
(49/165)
31.41%
(120/382)
0.71
Clinical pregnancy rate 45.86%
(643/1402)
46.34%
(38/82)
51.87%
(97/187)
0.30
Early miscarriage rate 6.84%
(44/643)
7.89%
(3/38)
10.31%
(10/97)
0.39
Ongoing pregnancy rate 41.16%
(577/1402)
42.68%
(35/82)
45.99%
(86/187)
0.44
........................................................................................
Table IV Comparison of outcomes of fresh IVF–
embryo transfer cycles among the three groups with
normal sperm parameters.
Group 1 Group 2 Group 3 P
Implantation rate 28.68%
(261/910)
30.91%
(17/55)
27.93%
(31/111)
0.92
Clinical pregnancy
rate
45.92%
(203/442)
44.44%
(12/27)
46.30%
(25/54)
0.99
Early miscarriage rate 5.42%
(11/203)
8.33%
(1/12)
12.00%
(3/25)
0.27*
Ongoing pregnancy
rate
41.40%
(183/442)
40.74%
(11/27)
38.89%
(21/54)
0.94
*Fisher’s exact test.
........................................................................................
Table V Comparison of outcome of fresh IVF–embryo
transfer cycles among the three groups with
oligozoospermia and azoospermia.
Group 1 Group 2 Group 3 P
Implantation rate 29.69%
(582/1960)
29.09%
(32/110)
32.84%
(89/271)
0.56
Clinical
pregnancy rate
45.83%
(440/960)
47.27%
(26/55)
54.14%
(72/133)
0.20
Early miscarriage
rate
7.50%
(33/440)
7.69%
(2/26)
9.72%
(7/72)
0.75*
Ongoing
pregnancy rate
41.04%
(394/960)
43.64%
(24/55)
48.87%
(65/133)
0.22
*Fisher’s exact test.
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dent factors are related to the outcome of IVF or ICSI treatment,
such as the sperm parameters mentioned above, a binary logistic
regression method was used to evaluate the odds of chromosomal
hetermorphism expression. Some variables in this model were con-
tinuous quantitative variables, but the effect of a one-unit change in
these variables had no practical meaning. Therefore, they were trans-
formed to categorical variables. The ratios of these variables among
the three groups were initially compared, and no differences were
found. Then, using a logistic regression model, it was found that
there were three confounding factors including ovarian stimulation
protocol, dosage of Gns and number of high-quality transferred
embryos. After accounting for the effect of these factors, no
adverse effect of chromosomal polymorphism variation on the
outcome of IVF/ICSI treatment was found.
Among the infertile couples who received the ﬁrst IVF/ICSI treat-
ment in our study, Y chromosome heteromorphism was the most
prevalent chromosome heteromorphism in the male partner
(7.84%). The heteromorphism changes of the Y chromosome
included increasing secondary constriction of the long arm (or the
so-called heterochromatic regions) and microdeletion of the Y
chromosome. The impacts of small Y chromosome, Y chromosome
azoospermia factors microdeletion and microdeletion of the
heat-shock-protein gene on infertility have also attracted attention
(Nagvenkar et al., 2005; Vinci et al., 2005). Some authors reported
studies of the relationship between Y chromosome microdeletion
and the outcome of ICSI treatment. For example, Kihaile et al.
(2005) compared reproductive outcomes following ICSI treatment
between those with Y chromosome microdeletions and those with
intact Y chromosomes in Japanese and African men with azoospermia
and oligozoospermia. They found that there were no signiﬁcant
differences in fertilization, blastocyst development, implantation and
pregnancy rates between the two groups. Choi et al. (2004) also
reported the outcomes of ICSI cycles in 17 patients with Y microdele-
tions. They found a trend toward lower fertilization rates in patients
with Y microdeletions but it did not reach statistical signiﬁcance,
while the CPR of the microdeletion group was similar to that of con-
trols. Two other articles also reported no impact of Y chromosome
microdeletion (Silber et al., 1998; van Golde et al., 2001).
In the present data, 13.04% of male partners displayed chromoso-
mal polymorphism variations, which had no adverse effect on preg-
nancy rates. Clinical and OPRs of Group 3 (male carriers of
chromosomal heteromorphism) showed no signiﬁcant differences.
Thus, we postulated that chromosomal heteromorphism in infertile
men may have no negative effect on IVF/ICSI treatment, which was
consistent with the results reported previously.
After thorough analysis of the karyotypes of chromosomal hetero-
morphism in male carriers, 60% of male carriers expressed hetero-
morphism of the Y chromosome, but only seven men were deﬁned
as Yqh2, while 93.55% had Yqh+. Thus, it appears that the potential
impact of Yqh+ on the outcome of IVF–embryo transfer treatment
should not be ignored. Antonelli et al. (2000) performed cytogenetic
analysis in 333 males with oligozoospermia and NOA who were
receiving IVF–embryo transfer treatment and found that too many
DNA repeats at speciﬁc regions of the Y chromosome may impact
on the pairing and synapsis of X and Y chromosomes during
meiosis. Minocherhomji et al. (2009) believe that the increase in the
long arm of the Y chromosome may inhibit the expression of genes
of spermatogenesis by position-effect variegation (PEV) and decrease
reproductive capacity. However, some other researchers do not
agree. For example, Kalantari et al. (2001) analyzed the chromosomes
and semen of infertile males, and they concluded that Y chromosome
......................................... ......................................... .....................................
.............................................................................................................................................................................................
Table VI Estimated OR for CPR, early miscarriage rate and OPR using the binary logistic regression model.
Clinical pregnancy rate Ongoing pregnancy rate Early miscarriage rate
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Female chromosomal polymorphic variations
carrier (Group 1)
a
0.993 (0.627–1.571) 0.974 1.034 (0.652–1.640) 0.887 1.210 (0.353–4.148) 0.761
Male chromosomal polymorphic variations
carrier (Group 2)
a
1.310 (0.955–1.795) 0.094 1.245 (0.907–1.708) 0.175 1.620 (0.774–3.392) 0.201
IVF or ICSI 1.294 (0.950–1.764) 0.102 1.288 (0.943–1.758) 0.112 0.824 (0.342–1.986) 0.667
Female partner age 1.053 (0.914–1.215) 0.474 0.984 (0.852–1.136) 0.827 1.121 (0.761–1.652) 0.564
Women basal FSH (IU/l) 1.224 (0.949–1.579) 0.120 1.248 (0.965–1.614) 0.091 0.889 (0.438–1.802) 0.743
Protocol of stimulation
b 0.428 (0.325–0.563) ,0.0001 0.423 (0.319–.561) ,0.0001 1.844 (0.887–3.835) 0.101
Sperm parameters 1.098 (0.920–1.310) 0.299 1.094 (0.916–1.307) 0.321 1.099 (0.661–1.825) 0.716
Dosage of Gn
c 0.739 (0.562–0.971) 0.030 0.758 (0.574–1.001) 0.051 1.106 (0.522–2.342) 0.792
E2 level on HCG day (pg/ml) 0.941 (0.817–1.084) 0.402 0.932 (0.808–1.076) 0.338 0.922 (0.619–1.374) 0.690
Thickness of endometrium on HCG day (cm) 1.267 (0.878–1.829) 0.205 1.438 (0.981–2.108) 0.062 0.622 (0.257–1.504) 0.292
No. of oocytes obtained 1.033 (0.855–1.247) 0.738 1.040 (0.860–1.258) 0.682 0.861 (0.511–1.450) 0.573
No. of high-quality embryos transferred
d 1.574 (1.345–1.843) ,0.0001 1.490 (1.269–1.749) ,0.0001 1.099 (0.674–1.793) 0.705
aOR: odds for the outcome of Groups 2 and 3 compared with Group 1.
bOR: relative change in odds on outcome comparing the short-term ovarian stimulation protocol to the long-term ovarian stimulation protocol.
cOR: relative change in odds for the outcome when the dosage of Gn is increased.
dOR: relative change in odds for the outcome when the number of high-quality embryo transferred is increased by 1 SD.
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ing results indicate that more data are needed to elucidate the effect of
Y chromosomal heteromorphism on spermatogenesis. In the present
study, with a high percentage of Yqh+ among male chromosomal het-
eromorphism carriers, Yqh+ appeared to have no adverse effect on
the pregnancy rate following IVF/ICSI treatment, despite a potential
impact on spermatogenesis.
In addition to Y chromosomal heteromorphism, there were other
heteromorphism types related to infertility: heteromorphisms shown
by short-arm regions of D and G group chromosomes and hetero-
morphisms shown by paracentric long-arm regions of chromosomes
1, 9 and 16, and inv(9) (Madon et al., 2005; Sahin et al., 2008;
Minocherhomji et al., 2009).
The increase in the length of the secondary constriction in the long
arm of chromosomes 1, 9 and 16 is also common in chromosome
polymorphism variations. Minocherhomji et al. (2009) found that
both infertile men and infertile women more frequently had a 9qh+
karyotype. In the present study, the secondary constriction in the
long arm of chromosomes 1, 9 and 16 was most common in
females with chromosome polymorphism variation (3.29%), and was
close to that in males with polymorphism variation (1.97%). The struc-
ture and function of these duplicate DNA sequences are still
unknown. The repeat in the distal chromosome segments may
cause clinical symptoms because of increased, highly repetitive,
DNA sequences (Hennig, 1999; Broccoli, 2004). Recent studies indi-
cate that heterochromatin in chromosomal polymorphism variations
regulates gene expression by an epigenetic mode, e.g. reversible trans-
formation between heterochromatin (non-coding DNA sequences)
and euchromatin (expressed DNA sequences) (Frenster and Herstein,
1973; Nakatsu et al., 1974). One other interesting point about hetero-
chromatin is known as positive-effect variegation, which is deﬁned as
silencing of a normally expressed gene when it is brought into juxtapo-
sition with pericentric heterochromatin (Cryderman et al., 1998).
D-genome and G-genome chromosomes are the other kinds of
common chromosome heteromorphisms. They were also common
in the present study (2.17% in men and 1.77% in women). These het-
eromorphisms show increased heterochromatin at the chromosome
telomere, the short arm of the chromosome, and the centromere,
as well as variants at the NOR. Heterochromatin located in centro-
meres has an essential role in spindle attachment and chromosome
movement, meiotic pairing and sister chromatid cohesion (Karpen
and Endow, 1998). When chromatin variation occurs in these
regions, it causes defects in centromere function and kinetochore
assembly, difﬁculty in homologous chromosome pairing, and impacts
on cell division. All of the above abnormalities could affect gamete
formation.
In the present study, both Groups 2 and 3 (infertile couples with
chromosomal heteromorphism) showed similar CPRs and OPRs com-
pared with the normal group. This ﬁnding suggests that, although vari-
ations in heterochromatin could affect gametogenesis and lead to
infertility, the efﬁciency of IVF–embryo transfer treatment would
not be affected. For instance, OAT and azoospermia due to a
decline in spermatogenesis could be resolved by the ICSI technique,
and ovarian stimulation could circumvent impaired oogenesis. In the
present study, logistic analysis also indicated that heteromorphism car-
riers could achieve the same pregnancy rate as normal karyotype
couples, when two or three high-quality embryos were transferred.
In addition to the above result, one other interesting ﬁnding in the
present study was that the couples with male chromosomal hetero-
morphism, but not female carriers, displayed a trend toward a
higher early miscarriage rate (10.31 versus 6.84%, P . 0.05), and
this phenomenon was more obvious in those couples with normal
sperm parameters (12.00% of Group 3 versus 5.42% in control
group, P . 0.05). Some authors pointed out that 41% of recurrent
miscarriages are aneuploid, and 15% of patients will have repeat aneu-
ploidy (Carp et al., 2008). In a study by Yakin et al. (2005), sperm ﬂu-
orescent in situ hybridization (FISH) analysis in NOA or OAT men with
9qh+ revealed an increased rate of sperm aneuploidy. The incidence
of Y chromosomal polymorphism variation was increased in male
partners of infertile couples in the present study, which could have
caused the slightly higher early miscarriage rate, even in those
without sperm parameter abnormality. Thus, in the future, more sen-
sitive techniques are needed to identify minor chromosomal variation,
e.g. analysis of aneuploidy in gametes by FISH or other molecular gen-
etics methods.
In summary, although past literature has indicated that there may be
some relationship between polymorphic variants of chromosomes and
infertility, the clinical and OPRs of IVF/ICSI treatment in the present
study did not appear to be affected; only the early miscarriage rate
of male carriers tended to be higher. However, the number of hetero-
morphism carriers was insufﬁcient. Furthermore, the chromosome
analysis method in the present study had a 400–550 BPHS banding
resolution; so some potential variations could not be distinguished
from common polymorphism variations. Therefore, a greater number
of samples and more sensitive techniques are needed for further study.
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